{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T14:31:54Z","timestamp":1791815514211,"version":"4.3.4"},"reference-count":41,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.jneuroim.2011.11.005","type":"journal-article","created":{"date-parts":[[2011,12,10]],"date-time":"2011-12-10T05:20:21Z","timestamp":1323494421000},"page":"52-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":140,"title":["Immune profiling of Alzheimer patients"],"prefix":"10.1016","volume":"242","author":[{"given":"Mariavaleria","family":"Pellican\u00f2","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anis","family":"Larbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Goldeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"Colonna-Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvio","family":"Buffa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Bulati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graziella","family":"Rubino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Iemolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"Candore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calogero","family":"Caruso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyna","family":"Derhovanessian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Pawelec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2011.11.005_bb0005","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","article-title":"Inflammation in Alzheimer's disease. Neuroinflammation working group","volume":"21","author":"Akiyama","year":"2000","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jneuroim.2011.11.005_bb0210","series-title":"American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders: DSM-III-R","year":"1987"},{"key":"10.1016\/j.jneuroim.2011.11.005_bb0015","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0074-7742(07)82011-3","article-title":"Systemic and acquired immune responses in Alzheimer's disease","volume":"82","author":"Britschgi","year":"2007","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.jneuroim.2011.11.005_bb0020","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1365-2249.2008.03785.x","article-title":"Cytomegalovirus-seropositivity has a profound influence on the magnitude of major lymphoid subsets within healthy individuals","volume":"155","author":"Chidrawar","year":"2009","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jneuroim.2011.11.005_bb0025","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/039463200802100104","article-title":"Expression and phosphorylation of protein kinase C isoforms in Abeta(1\u201342) activated T lymphocytes from Alzheimers disease","volume":"21","author":"Ciccocioppo","year":"2008","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.jneuroim.2011.11.005_bb0030","doi-asserted-by":"crossref","first-page":"4618","DOI":"10.4049\/jimmunol.1001629","article-title":"Hallmark features of immunosenescence are absent in familial longevity","volume":"185","author":"Derhovanessian","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2011.11.005_bb0035","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3233\/JAD-2005-7304","article-title":"Ineffective phagocytosis of amyloid-beta by macrophages of Alzheimer's disease patients","volume":"7","author":"Fiala","year":"2005","journal-title":"J. Alzheimers Dis."},{"issue":"5","key":"10.1016\/j.jneuroim.2011.11.005_bb0040","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.exger.2006.11.016","article-title":"Aging and T-cell diversity","volume":"42","author":"Goronzy","year":"2007","journal-title":"Exp. Gerontol."},{"issue":"2","key":"10.1016\/j.jneuroim.2011.11.005_bb0045","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1189\/jlb.72.2.233","article-title":"Interleukin-1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer's disease","volume":"72","author":"Griffin","year":"2002","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jneuroim.2011.11.005_bb0050","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1084\/jem.186.9.1407","article-title":"Phenotypic and functional separation of memory and effector human CD8+ T cells","volume":"186","author":"Hamann","year":"1997","journal-title":"J. Exp. Med."},{"issue":"10","key":"10.1016\/j.jneuroim.2011.11.005_bb0055","doi-asserted-by":"crossref","first-page":"6088","DOI":"10.4049\/jimmunol.174.10.6088","article-title":"Expression of killer cell lectin-like receptor G1 on antigen-specific human CD8+ T lymphocytes during active, latent, and resolved infection and its relation with CD57","volume":"174","author":"Ibegbu","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2011.11.005_bb0060","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1742-4933-5-6","article-title":"Multiparameter flow cytometric analysis of CD4 and CD8 T cellsubsets in young and old people","volume":"5","author":"Koch","year":"2008","journal-title":"Immun. Ageing"},{"issue":"1","key":"10.1016\/j.jneuroim.2011.11.005_bb0065","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3233\/JAD-2009-1015","article-title":"Dramatic shifts in circulating CD4 but not CD8 T cell subsets in mild Alzheimer's disease","volume":"17","author":"Larbi","year":"2009","journal-title":"J. Alzheimers Dis."},{"issue":"9","key":"10.1016\/j.jneuroim.2011.11.005_bb0070","doi-asserted-by":"crossref","first-page":"5778","DOI":"10.4049\/jimmunol.0803013","article-title":"Amyloid beta interaction with receptor for advanced glycation end products up-regulates brain endothelial CCR5 expression and promotes T cells crossing the blood\u2013brain barrier","volume":"182","author":"Li","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2011.11.005_bb0075","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0165-5728(99)00046-6","article-title":"Characterization of cytokine production, screening of lymphocyte subset patterns and in vitro apoptosis in healthy and Alzheimer's Disease (AD) individuals","volume":"97","author":"Lombardi","year":"1999","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2011.11.005_bb0080","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1212\/01.WNL.0000091890.32140.8F","article-title":"PlasmaA[beta]40 and A[beta]42 and Alzheimer's disease: relation to age, mortality, and risk","volume":"61","author":"Mayeux","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2011.11.005_bb0085","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Service Task Force on Alzheimer's Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2011.11.005_bb0090","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/360264a0","article-title":"Lifespan of human lymphocyte subsets defined by CD45 isoforms","volume":"360","author":"Michie","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2011.11.005_bb0095","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.neurobiolaging.2007.07.011","article-title":"Abeta(1\u201342) stimulated T cells express P-PKC-delta and P-PKC-zeta in Alzheimer disease","volume":"30","author":"Miscia","year":"2009","journal-title":"Neurobiol. Aging"},{"issue":"10","key":"10.1016\/j.jneuroim.2011.11.005_bb0100","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.exger.2004.07.007","article-title":"Increased plasma levels of soluble CD40, together with the decrease of TGF beta 1, as possible differential markers of Alzheimer disease","volume":"39","author":"Mocali","year":"2004","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.jneuroim.2011.11.005_bb0105","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1172\/JCI200318104","article-title":"Increased T cell reactivity to amyloid beta protein in older humans and patients with Alzheimer disease","volume":"112","author":"Monsonego","year":"2003","journal-title":"J. Clin. Invest."},{"issue":"12","key":"10.1016\/j.jneuroim.2011.11.005_bb0110","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1212\/WNL.57.12.2243","article-title":"Amyloid precursor protein in platelets: a peripheral marker for the diagnosis of sporadic AD","volume":"57","author":"Padovani","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2011.11.005_bb0115","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S1471-4906(02)02255-X","article-title":"Is human immunosenescence clinically relevant? Looking for \u2018immunological risk phenotypes\u2019","volume":"23","author":"Pawelec","year":"2002","journal-title":"Trends Immunol."},{"issue":"1","key":"10.1016\/j.jneuroim.2011.11.005_bb0120","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3233\/JAD-2010-091714","article-title":"Systemic immune responses in Alzheimer's disease: in vitro mononuclear cell activation and cytokine production","volume":"21","author":"Pellican\u00f2","year":"2010","journal-title":"J. Alzheimers Dis."},{"issue":"2","key":"10.1016\/j.jneuroim.2011.11.005_bb0125","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3233\/JAD-2008-14203","article-title":"Peripheral chemokine receptors, their ligands, cytokines and Alzheimer's disease","volume":"14","author":"Reale","year":"2008","journal-title":"J. Alzheimers Dis."},{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2011.11.005_bb0130","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jpsychires.2006.01.010","article-title":"Altered lymphocyte distribution in Alzheimer's disease","volume":"41","author":"Richartz-Salzburger","year":"2007","journal-title":"J. Psychiatr. Res."},{"issue":"1","key":"10.1016\/j.jneuroim.2011.11.005_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.arcmed.2007.10.001","article-title":"Neuroinflammation: implications for the pathogenesis and molecular diagnosis of Alzheimer's disease","volume":"39","author":"Rojo","year":"2008","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.jneuroim.2011.11.005_bb0140","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.4049\/jimmunol.178.7.4112","article-title":"Four functionally distinct populations of human effector-memory CD8+ T lymphocytes","volume":"178","author":"Romero","year":"2007","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.jneuroim.2011.11.005_bb0145","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3233\/JAD-2010-101248","article-title":"Impaired lipoprotein receptor-mediated peripheral binding of plasma amyloid-beta is an early biomarker for mild cognitive impairment preceding Alzheimer's disease","volume":"24","author":"Sagare","year":"2011","journal-title":"J. Alzheimers Dis."},{"issue":"6754","key":"10.1016\/j.jneuroim.2011.11.005_bb0150","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/44385","article-title":"Two subsets of memory T lymphocytes with distinct homing potentials and effector functions","volume":"401","author":"Sallusto","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2011.11.005_bb0155","doi-asserted-by":"crossref","first-page":"927","DOI":"10.3233\/JAD-2010-091696","article-title":"PD1 negative and PD1 positive CD4+T regulatory cells in mild cognitive impairment and Alzheimer's disease","volume":"21","author":"Saresella","year":"2010","journal-title":"J. Alzheimers Dis."},{"issue":"37","key":"10.1016\/j.jneuroim.2011.11.005_bb0160","doi-asserted-by":"crossref","first-page":"14052","DOI":"10.1073\/pnas.0805902105","article-title":"Peripheral Abeta subspecies as risk biomarkers of Alzheimer's disease","volume":"105","author":"Schupf","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.jneuroim.2011.11.005_bb0165","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3233\/JAD-2001-3111","article-title":"Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein","volume":"3","author":"Selkoe","year":"2001","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.jneuroim.2011.11.005_bb0170","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.neurobiolaging.2006.05.020","article-title":"Lymphocyte subset patterns and cytokine production in Alzheimer's disease patients","volume":"28","author":"Speciale","year":"2007","journal-title":"Neurobiol. Aging"},{"issue":"1\u20133","key":"10.1016\/j.jneuroim.2011.11.005_bb0175","first-page":"77","article-title":"Increased expression of NK cell markers on T lymphocytes in aging and chronic activation of the immune system reflects the accumulation of effector\/senescent T cells","volume":"121","author":"Tarazona","year":"2000","journal-title":"Mech. Ageing Dev."},{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2011.11.005_bb0180","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0165-5728(01)00496-9","article-title":"Occurrence of T cells in the brain of Alzheimer's disease and other neurological diseases","volume":"124","author":"Togo","year":"2002","journal-title":"J. Neuroimmunol."},{"issue":"3","key":"10.1016\/j.jneuroim.2011.11.005_bb0215","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1385\/NMM:7:3:255","article-title":"T-cells in Alzheimer's disease","volume":"7","author":"Town","year":"2005","journal-title":"Neuromolecular Med."},{"issue":"1\u20133","key":"10.1016\/j.jneuroim.2011.11.005_bb0190","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000289225","article-title":"Increased CD44 gene expression in lymphocytes derived from Alzheimer disease patients","volume":"7","author":"Uberti","year":"2010","journal-title":"Neurodegener. Dis."},{"issue":"9","key":"10.1016\/j.jneuroim.2011.11.005_bb0195","doi-asserted-by":"crossref","first-page":"4838","DOI":"10.4049\/jimmunol.167.9.4838","article-title":"Viral infections induce abundant numbers of senescent CD8 T cells","volume":"167","author":"Voehringer","year":"2001","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.jneuroim.2011.11.005_bb0200","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1182\/blood-2002-02-0657","article-title":"Lack of proliferative capacity of human effector and memory T cells expressing killer cell lectinlike receptor G1 (KLRG1)","volume":"100","author":"Voehringer","year":"2002","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.jneuroim.2011.11.005_bb0205","first-page":"1141","article-title":"Premature immunosenescence in rheumatoid arthritis","volume":"29","author":"Weyand","year":"2002","journal-title":"J. Rheumatol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572811003055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572811003055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:18:15Z","timestamp":1759047495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572811003055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":41,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0165572811003055"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2011.11.005","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune profiling of Alzheimer patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2011.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}